MYD88 and inflammatory response: Inhalation of a MyD88 inhibitor (ST2825) and SalB significantly reduced PM2.5-induced acute airway inflammation and oxidative stress, reduced the release of inflammatory cytokines, and prevented the increase of ROS and the reduction of antioxidant factors in lung tissue and in human epithelial cells.